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Summary
Lung transplantation was first performed in 1963, but the real increase in performed tran-
splantations occurred in the last twenty years. Leading indications for lung transplantation are: 
chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, cystic fibrosis, pulmonary 
arterial hypertension, and sarcoidosis. Careful selection of donors is extremely important for 
prognosis after transplantation. Physicians should consider lung transplantation as a therapeutic 
option and follow the guidelines on the indications for transplantation so patients could be sent 
on time to a referral center for all the necessary examinations and preparation for recruiting to 
the waiting list. Department for Lung Diseases Jordanovac, University Hospital Centre Zagreb, is 
a referral center for lung transplantation in Croatia. The Department is performing processing and 
preparing patients for transplantation as well as follow them during post-transplantation period.
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Introduction
Lung transplation is today indicated like last therapeutic option for patients 
with end-stage lung diseases in which all conservative options are exhausted. First 
lung transplantation was performed in 1963. [1]. However, further twenty years 
were needed to get some modest clinically significant survival benefit after the pro-
cedure. With these encouraging results, in the last twenty years significant increase 
in number of lung transplantation was noticed. Today, more than 32 000 procedures 
were performed in the World [2]. Lung transplantation from rare medical procedure 
has become a standard of care in patients with terminal stage of lung disease. 
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Indications for lung transplantion 
In the last decade indications for lung transplantation significantly broadened 
and include large spectrum of airway, lung parenchymal and pulmonary vascula-
ture diseases. Nowadays, most common indication for lung transplantation is chro-
nic obstructive pulmonary disease (COPD) and represents around one third of all 
procedures [3], (Figures 1 and 2).
Figure 1. X ray of COPD patient before 
transplantation
Figure 2. X ray of COPD patient after trans-
plantation
Idiopathic pulmonary fibrosis (IPF) is the second most common indication, with 
constant increase in number of transplanted patients. IPF has become the most com-
mon reason for lung transplantation in the United States [4], (Figures 3 and 4).
Cystic fibrosis (CF) is responsible for 15% of all transplantations. Less common 
indications are emphysema of the lung due to α1 – antitrypsin deficiency, sarcoido-
sis, bronchiectasis and lymphangioleiomyomatosis (LAM), [3]. Idiopathic pulmo-
nary arterial hypertension (IPAH) used to be the most common indication for lung 
transplantation, but today is cause of only 2% of all transplantations [2]. Significant 
decrease in number of transplantations in these patients is clear indicator of great 
improvement in conservative treatment of patients with IPAH (Figures 5 and 6).
Some indications are still largely debatable. Lung transplantation in patients 
with lung diseases associated with connective tissue diseases can lead to significant 
post – transplantation mortality because of a large spectrum of extra – pulmonary 
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Figure 3. X –ray of patient with idiopathic 
pulmonary fibrosis before transplantation
Figure 5. X ray of patient with pulmonary 
arterial hypertension before transplantation
Figure 4. X –ray of patient with idiopathic 
pulmonary fibrosis after transplantation
Figure 6. X ray of patient with pulmonary 
arterial hypertension after transplantation
manifestations in these patients. After thorough medical checkup, in selected pa-
tients with little or no extra-pulmonary manifestation lung transplantation can be 
performed [5]. Attempts to treat very early stages of lung cancer resulted in high rate 
of recurrence. Therefore, lung cancer is nowadays considered to be a contraindicati-
on for lung transplantation [6].
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Contraindications for lung transplantation
There is surprisingly small number of absolute contraindications for lung tran-
splantation. Absolute contraindications are: recent malignancy (except carcinoma 
of the skin), active hepatitis B and C with liver damage, active smoking, alcohol and 
drugs abuse, severe psychiatric disorder, non – compliance with medical procedu-
res, poor social status and HIV infection [3]. Controlled diabetes, osteoporosis and 
coronary artery disease are not considered absolute contraindications [6].
In majority of transplantation centers, upper age limit for the procedure is 65 ye-
ars. In some centers, attempts are done to move the upper limit according to functi-
onal status and not only age. Greatest improvement is achieved in the United States 
were almost 20% of all transplanted patients were older than 65 [4].
Mechanically ventilated patients were for a long time considered not to be can-
didates for lung transplantation due to high post-transplantation morbidity and 
mortality. However, improvements in technology and introduction of extra – corpo-
real membranous oxygenation (ECMO) have removed that as contraindication and 
patients on oxygenation support can be successfully transplanted in experienced 
centers [8].
Chronic infections of sinuses and lower respiratory tract are great problem in 
patients with cystic fibrosis. Chronic infections with vast majority of pathogens (like 
Pseudomonas aeruginosa) are nowadays not a contraindication for transplantation. 
Only chronic infection with Burkholderia is the contraindication for transplantation 
due to high post – operative mortality [3,9].
When to list patients for transplantation?
When to put patient on transplantation waiting list is not easy to determine. Pa-
tients became candidates for transplantation in the late stage of their disease when 
survival is more likely better with transplantation comparing to conservative tre-
atment [3]. But it is extremely important to estimate a moment when patients are 
still capable of undergoing the procedure. It is really important to sensitize patients, 
their families and physicians not to hesitate to refer patients to expert center to esti-
mate the right indication and ideal timing for putting patients on the waiting list [3].
Criteria for referring patient to referral center are shown on Table 1 [10].
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Table 1. Criteria for lung tranplantation in most common indications
Chronic obstructive pulmonary disease
BODE index 7-10
Frequent exacerbations 
pCO2 >50mmHg at rest
Oxygen dependent
Pulmonary hypertension, cor pulmonale
FEV1 <20%, DLCO <20%, emphysema
6-MWT  300 m
BMI
Pulmonary arterial hypertension 
NYHA III-IV
Progression regardless of treatment
Walking distance <300 m on 6-MWT
Cardiac index <2L/min/m2
Right atrial pressure >15mmHg
Cystic fibrosis and bronchiectasis
FEV1 <30% or fast descrease in FEV1, especially in younger age
Exacerbations, ICU days 








UIP – histological or radiological finding
DLCO <35%
Decrease in  FVC >10% in the last 6 months
SHbO2 <88% during 6-MWT
Honeycombing HRCT (fibrosis score > 2)
Histological NSIP: 
- DLCO < 35%
- FVC of 10% or DLCO of 15%
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Lung transplantation programme in Croatia
First lung transplantation was performed in Croatia in year 2003. After that, pro-
gramme wasn’t continued due to lack of specific surgical equipment. That was the 
reason why we started co-operation with Professor Walter Klepetko from Universi-
ty Hospital AKH in Vienna. He is recognized as one of the World leading surgeons 
in the field of thoracic surgery, and especially lung transplantation. Until now, his 
center performed around 3000 transplantations with one year survival of more than 
90%, and 5-year survival of around 70%. Our collaboration started formally in 2011 
and consisted of four different procedures: lung transplantation, lung transplantati-
on with reconstructive cardiac surgery, lung and heart transplantation and pulmo-
nary endarterectomy (PEA), (Figure 7).
Figure 7. Surgical specimen obtained by pulmonary endarterectomy
AKH Vienna is responsible for surgical procedures, early post-operative care 
and regular post – transplantation evaluations. Head of post-transplantation eva-
luation team in Vienna is dr Peter Jaksch. Croatian part of the programme is loca-
ted at Department for Respiratory Diseases Jordanovac, University Hospital Centre 
Zagreb. Head of that part of the programme is Professor Miroslav Samaržija, his 
team consists of 5 physicians and 3 nurses who are responsible for screening, pre-
transplantation evaluation, recruitment of patients to Vienna and Euro-Transplant 
active list, transport of patients, rehabilitation and comprehensive post-transplan-
tation care. 
21
Rad 522. Medical Sciences, 41(2015) : 15-23
M. Samaržija, G. Redžepi, W. Klepetko, M. Jakopović: Lung transplantation programme in Croatia
After start of collaboration until now 157 patients were enrolled in the program-
me. Lung transplantation was performed in 34 patients, lung and heart transplan-
tation in two patients and PEA in 8 patients. Detailed number of patients in the 
programme is shown in Table 2 and Table 3. 
Table 2. Number of patients in lung transplantation programme
Total number - 118 
Performed  - 34 (1 re-LuTx) 
Waiting list – 5 
Accepted from AKH – 10 
Patients in screening – 26 
Screening failures - 7 
Patients died after transplantation - 6
Patient died on waiting list – 1 
Patients died in screening period – 18 
Table 3. Number of patients in pulmonary endarterctomy programme 
Total number - 29 
Performed – 8
Patients in screening – 6 
Screening failure – 3 
Died after PEA – 2
Died in screening period – 2 
Survival and rate of complications of Croatian patients is similar to whole Vie-
nna cohort. Huge improvement was done when ECMO was introduced as essential 
part of pre- and post-transplantation support. Indications for ECMO are shown in 
Table 4.
Table 4. Indication for extracoropreal life support
CO2 removal
Bridge to recovery 
Bridge to transplantation (lung ± heart)
Post transplantation support
Another step forward was done in last year when first successful re-transplan-
tation of the lung was done in patient with chronic rejection. Programme is also 
expanded to children with end-stage lung diseases. 
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Conclusion
Lung translation program which started 4 years ago is fully implement in regu-
lar medical care of severe respiratory diseases. This program significantly reduced 
mortality and improved quality of life of these patients. At the same time develo-
pment of this programme enables introduction of new diagnostic and therapeu-
tic methods and improved general knowledge in the field of respiratory medicine, 
especially in the treatment of critically and severely ill patients. The collaboration 
with AKH enables Croatian physicians to get specific education as well as to impro-
ve scientific collaboration between the two institutions.  
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Sažetak
Transplantacija pluća u Hrvatskoj
Transplantacija pluća prvi puta je učinjena 1963. godine, no pravi uzlet doživjela je tek 
unazad dvadeset godina. Vodeće indikacije za transplantaciju pluća su: kronična opstruktiv-
na plućna bolest, idiopatska plućna fibroza, cistična fibroza, plućna arterijska hipertenzija te 
sarkoidoza. Pažljiv odabir donora iznimno je važan za prognozu i ishod postupka. Liječnici bi 
trebali razmišljati o transplantaciji pluća kao terapijskoj opciji te pratiti smjernice o indikacijama 
za transplantaciju kako bi bolesnike na vrijeme uputili u referalni centar radi pripreme i obrade. 
Klinika za plućne bolesti Jordanovac, Kliničkog bolničkog centra Zagreb, referalni je centar za 
transplantaciju pluća u Hrvatskoj. U Klinici se provodi obrada i priprema bolesnika za transplan-
taciju te posttransplantacijsko liječenje i praćenje. 
Ključne riječi: transplantacija; pluća; referalni centar.
Corresponding author: 
Miroslav Samaržija
E-mail: miroslav.samarzija@kbc-zagreb.hr
